Toggle navigation
Login
Cart
Contact Us
Search
Search
Morris J. Birnbaum MD, PhD
Pfizer Inc.
Appearances
Therapeutic Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease
Clinical Translation: Unmet Needs
DGAT2 Inhibition for NASH
Pathways to NASH
Emerging Therapies for NASH
×
Shopping Cart
Item
Price
Remove
